Irritable bowel syndrome. Progress in understanding and management.
D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D004041:Dietary Fats / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage; D012812:Sigmoidoscopy; D014149:Tranquilizing Agents / Q000008:administration & dosage
D002121:Calcium Channel Blockers; D004041:Dietary Fats; D004044:Dietary Proteins; D009566:Nitrates; D010276:Parasympatholytics; D014149:Tranquilizing Agents